High materiality8/10
Nuvectis Pharma price target raised to $39 from $13 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $39; current price $14.96; priceChangeSinceSignal 3.11.
- Wainwright raises NVCT PT to $39; price $14.96 (+$3.11).
Key facts
- 01
Target: $39
- 02
Posted price: $14.96
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.